Iridex (IRIX) Total Non-Current Liabilities (2011 - 2026)
Iridex (IRIX) recorded quarterly Total Non-Current Liabilities of $23.1 million in Q2 2026, down 3.1% quarter-over-quarter from $23.8 million in Q1 2026, and down 14.73% on a YoY basis from $27.1 million in Q2 2025.
Iridex (IRIX) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Iridex's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $23.1 million for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 14.73% year-over-year to $23.1 million; the TTM figure through Apr 2026 stood at $23.1 million (down 14.73% YoY), while the FY2026 annual figure was $23.8 million, down 10.78% from the prior year.
- Total Non-Current Liabilities was $23.1 million for Q2 2026 at Iridex, down from $23.8 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $27.3 million in Q1 2024 to a low of $22.7 million in Q3 2023.
- Historically, Total Non-Current Liabilities has averaged $25.4 million across 5 years, with a median of $25.3 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities soared 139.7% in 2022, then slipped 15.3% in 2023.
- A 5-year view of Total Non-Current Liabilities shows it stood at $25.0 million in 2022, then slipped by 0.81% to $24.8 million in 2023, then rose by 7.98% to $26.7 million in 2024, then dropped by 12.6% to $23.4 million in 2025, then fell by 1.09% to $23.1 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $23.1 million (Q2 2026), $23.8 million (Q1 2026), and $23.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Iridex | 19.91 Mn | 15.31 Mn | 4.74 Mn | 23.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 23.10 Mn |
| Jan 3, 2026 | 23.84 Mn |
| Sep 27, 2025 | 23.36 Mn |
| Jun 28, 2025 | 25.22 Mn |
| Mar 29, 2025 | 27.09 Mn |
| Dec 28, 2024 | 26.72 Mn |
| Sep 28, 2024 | 27.21 Mn |
| Jun 29, 2024 | 26.70 Mn |
| Mar 30, 2024 | 27.30 Mn |
| Dec 30, 2023 | 24.75 Mn |
| Sep 30, 2023 | 22.75 Mn |
| Jul 1, 2023 | 23.46 Mn |
| Apr 1, 2023 | 25.07 Mn |
| Dec 31, 2022 | 24.95 Mn |
| Oct 1, 2022 | 26.86 Mn |
| Jul 2, 2022 | 26.14 Mn |
| Apr 2, 2022 | 26.67 Mn |
| Jan 1, 2022 | 25.36 Mn |
| Oct 2, 2021 | 25.20 Mn |
| Jul 3, 2021 | 23.62 Mn |